Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
J Am Coll Cardiol. 2017 Jan 17;69(2):211-235. doi: 10.1016/j.jacc.2016.10.064.
In the second part of this 2-part series on pacemakers, we present recent advances in pacemakers and preview future developments. Cardiac resynchronization therapy (CRT) is a potent treatment for heart failure in the setting of ventricular dyssynchrony. Successful CRT using coronary venous pacing depends on appropriate patient selection, lead implantation, and device programming. Despite optimization of these factors, nonresponse to CRT may occur in one-third of patients, which has led to a search for alternative techniques such as multisite pacing, His bundle pacing, and endocardial left ventricular pacing. A paradigm shift in pacemaker technology has been the development of leadless pacemaker devices, and on the horizon is the development of batteryless devices. Remote monitoring has ushered in an era of greater safety and the ability to respond to device malfunction in a timely fashion, improving outcomes.
在这篇关于起搏器的两部分系列文章的第二部分中,我们介绍了起搏器的最新进展,并展望了未来的发展。心脏再同步治疗(CRT)是心室不同步性心力衰竭的有效治疗方法。成功的 CRT 依赖于经冠状静脉起搏的合适患者选择、导线植入和设备编程。尽管对这些因素进行了优化,但 CRT 的无应答仍可能发生在三分之一的患者中,这导致了对替代技术的探索,如多点起搏、希氏束起搏和心内膜左心室起搏。起搏器技术的范式转变是无导线起搏器设备的发展,而在不远的将来,还将开发无电池设备。远程监测开创了一个更加安全的时代,能够及时响应设备故障,从而改善治疗效果。